Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
2005
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
1992 Standout
Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer
1994
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Epidemiology of prostate cancer
1997
Effects of Muscle Strength Training and Megestrol Acetate on Strength, Muscle Mass, and Function in Frail Older People
2006
Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents
2014
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Epidemiology of Prostate Cancer
2019 Standout
The development of androgen-independent prostate cancer
2001 Standout
Cancer-associated cachexia
2018 Standout
Effects of Testosterone Replacement and/or Resistance Exercise on the Composition of Megestrol Acetate Stimulated Weight Gain in Elderly Men: A Randomized Controlled Trial
2002
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Polycystic Ovary Syndrome
2005 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
2016 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
1998
HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
1996
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Endocrine Therapy of Breast and Prostate Cancer
1989
Comparison of Prostatic Cancer Tissue Dihydrotestosterone Levels at the Time of Relapse Following Orchiectomy or Estrogen Therapy
1984
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Nonoperative Management of Benign Prostatic Hyperplasia
1989
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Clinical and Experimental Studies of Benign Prostatic Hyperplasia
1990
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Binding of a 4-Methyl-4-Aza-Steroid to 5α-Reductase of Rat Liver and Prostate Microsomes
1983
Expression and Characterization of Recombinant Type 2 3α-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3α/17β-HSD Activity and Cellular Distribution
1997
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Control over overall shape and size in de novo designed proteins
2015 StandoutNobel
The pathogenesis of benign prostatic hyperplasia
1980 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
Skeletal complications of malignancy
1997 Standout
The Influence of Age, Alcohol Consumption, and Body Build on Gonadal Function in Men*
1980
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
1980
The Androgen Axis in Recurrent Prostate Cancer
2004
Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone
1984
Works of Suzanne Geller being referenced
A method for tissue extraction and determination of prostate concentrations of endogenous androgens by radioimmunoassay
1976
Acute therapy with megestrol acetate decreases nuclear and cytosol androgen receptors in human BPH tissue
1982
DHT Concentrations in Human Prostate Cancer Tissue*
1978
Medical Castration of Males with Megestrol Acetate and Small Doses of Diethylstilbestrol*
1981
Prostate concentrations of endogenous androgens by radioimmunoassay
1976
Effect of Megestrol Acetate (Megace®) on Steroid Metabolism and Steroid-Protein Binding in the Human Prostate
1976
COMPARISON OF ANDROGEN METABOLITES IN BENIGN PROSTATIC HYPERTROPHY (BPH) AND NORMAL PROSTATE
1976